Aegis Capital Starts SciSparc Ltd () (SPRCY) at Buy
- Tech stocks push S&P 500 to record close, buoy Nasdaq
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Coinbase (COIN) direct listing IPO reference price set at $250
- Biggest SPAC Deal Ever: Grab To Go Public in a $40 Billion Merger With Altimeter (AGC), Backed by Fidelity and BlackRock
- Oil rises after robust China data but J&J vaccine pause weighs
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Aegis Capital analyst Nathan Weinstein initiates coverage on SciSparc Ltd () (OTC: SPRCY) with a Buy rating and a price target of $20.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JMP Securities Starts Shutter Rock Capital Corp. (SSSS) at Market Outperform
- VAT Group AG (VACN:SW) PT Raised to CHF280 at Deutsche Bank
- CIBC Starts MAG Silver (MAG:CN) (MAG) at Neutral
Create E-mail Alert Related CategoriesIntl Ratings, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!